Annual report
9220.TEDINET S100RAW5
Period2022-04-01 → 2023-03-31
Filed2023-06-30
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 130
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥9.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥9.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥544m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥650m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥737m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥648m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥608m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥532m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥696m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥710m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥445m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥529m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥477m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥486m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥445m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥529m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥9.0bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥7.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥8.3bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥8.0bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.0bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥5.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.5bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥632m | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.8bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥976m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥970m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥899m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥847m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥849m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥97m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥112m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥130m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥464m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥879m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥374m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥370m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥167.39 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥240.32 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥238.53 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥242.76 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,135.13 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥913.16 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥673.99 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥313.17 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 33.7% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.8% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 7.9% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 17.6% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 30.3% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 45.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 76.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,011 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 985 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 999 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 1,051 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥9.3bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥8.8bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥8.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥523m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥581m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥713m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥578m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥546m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥581m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥420m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥705m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥548m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥461m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥368m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥502m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥495m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥236m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥8.9bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥7.5bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥7.8bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.2bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.3bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.9bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.6bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.9bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.5bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥663m | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥688m | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.2bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥173.29 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥167.07 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥250.97 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥247.56 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,180,342.28 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥33 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,097.79 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥860.61 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥694.69 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥331.59 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,441,562.86 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 33.2% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.2% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 9.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 9.4% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 19.1% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.5% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 45.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 73.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 41.5% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,676,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,200,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,200,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 200 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 200 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 952 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 938 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 888 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 840 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 785 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥3m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥2.9bn |
| Nursing Care Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥761m |
| Nursing Care Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥277m |
| Nursing Care Businessreportable segment | employees | at 2023-03-31 | 645 pure |
| Nursing Care Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥5.2bn |
| Nursing Care Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥5.2bn |
| Nursing Care Businessreportable segment | segment assets | at 2023-03-31 | ¥5.0bn |
| Nursing Care Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥197m |
| Nursing Care Equipment Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥14m |
| Nursing Care Equipment Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥30m |
| Nursing Care Equipment Businessreportable segment | employees | at 2023-03-31 | 316 pure |
| Nursing Care Equipment Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥4.4bn |
| Nursing Care Equipment Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥4.4bn |
| Nursing Care Equipment Businessreportable segment | segment assets | at 2023-03-31 | ¥1.2bn |
| Nursing Care Equipment Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥347m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥775m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥307m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥9.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥9.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥6.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥544m |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥6m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥2.2bn |
| Nursing Care Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥59m |
| Nursing Care Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥282m |
| Nursing Care Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥5.1bn |
| Nursing Care Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥5.1bn |
| Nursing Care Businessreportable segment | segment assets | at 2022-03-31 | ¥4.3bn |
| Nursing Care Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥378m |
| Nursing Care Equipment Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥14m |
| Nursing Care Equipment Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥27m |
| Nursing Care Equipment Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥4.0bn |
| Nursing Care Equipment Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.0bn |
| Nursing Care Equipment Businessreportable segment | segment assets | at 2022-03-31 | ¥1.1bn |
| Nursing Care Equipment Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥272m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥73m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥309m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥9.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥9.2bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥650m |
| Nursing Care Businessreportable segment | employees | at 2023-03-31 | 591 pure |
| Nursing Care Equipment Businessreportable segment | employees | at 2023-03-31 | 311 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,372
| Item | Context | Value | Unit |
|---|---|---|---|
| Accounts payable other | CurrentYearInstant | 645081000 | JPY |
| Income taxes payable | Prior1YearInstant | 99467000 | JPY |
| Income taxes payable | CurrentYearInstant | 212252000 | JPY |
| Contract liabilities | Prior1YearInstant | 32241000 | JPY |
| Contract liabilities | CurrentYearInstant | 26344000 | JPY |
| Provision for bonuses | Prior1YearInstant | 376015000 | JPY |
| Provision for bonuses | CurrentYearInstant | 344290000 | JPY |
| Other cl | Prior1YearInstant | 80646000 | JPY |
| Other cl | CurrentYearInstant | 141877000 | JPY |
| Current liabilities | Prior1YearInstant | 2227774000 | JPY |
| Current liabilities | CurrentYearInstant | 2689490000 | JPY |
| Long term loans payable | Prior1YearInstant | 2916433000 | JPY |
| Long term loans payable | CurrentYearInstant | 2692284000 | JPY |
| Lease obligations ncl | Prior1YearInstant | 8875000 | JPY |
| Lease obligations ncl | CurrentYearInstant | 8483000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 25313000 | JPY |
| Net defined benefit liability | CurrentYearInstant | 23812000 | JPY |
| Long term accounts payable other | Prior1YearInstant | 268323000 | JPY |
| Long term accounts payable other | CurrentYearInstant | 299444000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 190609000 | JPY |
| Asset retirement obligations ncl | CurrentYearInstant | 209363000 | JPY |
| Other ncl | Prior1YearInstant | 52446000 | JPY |
| Other ncl | CurrentYearInstant | 58560000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 3462000000 | JPY |
| Noncurrent liabilities | CurrentYearInstant | 3291947000 | JPY |
| Liabilities | Prior1YearInstant | 5689774000 | JPY |
| Liabilities | CurrentYearInstant | 5981438000 | JPY |
| Capital stock | Prior1YearInstant | 190000000 | JPY |
| Capital stock | CurrentYearInstant | 496544000 | JPY |
| Capital surplus | Prior1YearInstant | 180000000 | JPY |
| Capital surplus | CurrentYearInstant | 486544000 | JPY |
| Retained earnings | Prior1YearInstant | 1638867000 | JPY |
| Retained earnings | CurrentYearInstant | 2049009000 | JPY |
| Shareholders equity | Prior1YearInstant | 2008867000 | JPY |
| Shareholders equity | CurrentYearInstant | 3032097000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 85000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | 5520000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 85000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 5520000 | JPY |
| Net assets | Prior1YearInstant | 2008953000 | JPY |
| Net assets | CurrentYearInstant | 3037618000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 7698728000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 9019056000 | JPY |
| Net sales | Prior1YearDuration | 9185911000 | JPY |
| Net sales | CurrentYearDuration | 9619401000 | JPY |
| Cost of sales | Prior1YearDuration | 7629034000 | JPY |
| Cost of sales | CurrentYearDuration | 8065736000 | JPY |
| Gross profit | Prior1YearDuration | 1556877000 | JPY |
| Gross profit | CurrentYearDuration | 1553664000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 907355000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |